Frequency Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Frequency Therapeutics's estimated annual revenue is currently $24M per year.
- Frequency Therapeutics received $42.0M in venture funding in January 2019.
- Frequency Therapeutics's estimated revenue per employee is $828,276
- Frequency Therapeutics's total funding is $180.3M.
- Frequency Therapeutics's current valuation is $177.9M. (January 2022)
Employee Data
- Frequency Therapeutics has 29 Employees.
- Frequency Therapeutics grew their employee count by -53% last year.
Frequency Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | SVP Research | Reveal Email/Phone |
3 | SVP, Corporate Affairs | Reveal Email/Phone |
4 | Head Intellectual Property | Reveal Email/Phone |
5 | VP Information Technology | Reveal Email/Phone |
6 | VP - Medicinal and Process Chemistry | Reveal Email/Phone |
7 | SVP - Strategic Marketing and New Product Planning | Reveal Email/Phone |
8 | EVP, Translational Medicine | Reveal Email/Phone |
9 | VP Finance and Operations | Reveal Email/Phone |
10 | Chief Manufacturing Officer | Reveal Email/Phone |
Frequency Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Frequency Therapeutics?
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.
keywords:N/A
$180.3M
Total Funding
29
Number of Employees
$24M
Revenue (est)
-53%
Employee Growth %
$177.9M
Valuation
N/A
Accelerator
Frequency Therapeutics News
Frequency Therapeutics Inc (FREQ) stock is lower by -80.79% over the last 12 months, and the average rating from Wall Street analysts is a...
Frequency Therapeutics, the biotechnology company responsible for the new treatment, was founded in part by scientists from MIT.
The biotechnology company Frequency Therapeutics is seeking to reverse hearing loss not with hearing aids or implants, but with a new kind...
Hearing loss affects millions of Americans but to date, there are no FDA-approved medicines to treat them. Frequency Therapeutics is ...
Other Companies in Woburn
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.5M | 29 | -34% | N/A |
#2 | $3.5M | 29 | 26% | N/A |
#3 | $5.9M | 29 | 4% | N/A |
#4 | $3.5M | 30 | -3% | N/A |
#5 | $5M | 30 | 11% | N/A |
Frequency Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-04-12 | $32.0M | A | CoBro Ventures | Article |
| 2019-01-08 | $42.0M | B | Taiwania Capital Management | Article |